XML 60 R59.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation (Detail) - Summary Of Changes In SARs Outstanding (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
SARs    
Granted (in shares) 300,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod  
Weighted- Average Remaining Contractual Term    
Granted 2 years 73 days  
Stock Appreciation Rights (SARs)    
SARs    
Outstanding at December 31, 2013 (in shares) 1,600,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Granted (in shares) 400,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Forfeited (in shares) (100,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Exercised (in shares) (500,000)it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Outstanding at December 31, 2014 (in shares) 1,400,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
[1],[2] 1,600,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Vested and exercisable at December 31, 2014 (in shares) 600,000it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestExercisableNumber
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
[1]  
Per Share Weighted- Average Exercise Price    
Outstanding at December 31, 2013 (in Dollars per share) $ 34.14it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Granted (in Dollars per share) $ 64.64it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Exercised (in Dollars per share) $ 24.12it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Outstanding at December 31, 2014 (in Dollars per share) $ 44.44it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
[1],[2] $ 34.14it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Vested and exercisable at December 31, 2014 (in Dollars per share) $ 33.36it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
[1]  
Per Share Weighted- Average Grant Date Fair Value    
Outstanding at December 31, 2013 (in Dollars per share) $ 11.63us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Granted (in Dollars per share) $ 14.99us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Exercised (in Dollars per share) $ 8.82it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
 
Outstanding at December 31, 2014 (in Dollars per share) $ 13.26us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
[1],[2] $ 11.63us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
Vested and exercisable at December 31, 2014 (in Dollars per share) $ 11.62it_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= us-gaap_StockAppreciationRightsSARSMember
[1]  
Weighted- Average Remaining Contractual Term    
Outstanding at December 31, 2013 4 years 125 days [1],[2] 4 years 124 days
Granted 6 years 40 days  
Outstanding at December 31, 2014 4 years 125 days [1],[2] 4 years 124 days
Vested and exercisable at December 31, 2014 3 years 82 days [1]  
[1] At December 31, 2014, 0.8 million of these SARs were unvested. The Company expects that substantially all of these unvested awards will vest in future periods.
[2] At December 31, 2014, SARs outstanding had an intrinsic value of $58.5 million. SARs vested and exercisable had an intrinsic value of $30.8 million.